Edinburg, TX (February 7, 2022) – DHR Health Institute for Research & Development has been granted Expanded Access by the FDA to offer fourth dose of Pfizer COVID-19 mRNA vaccine. DHR Health Institute for Research & Development is the first and only entity in the US which has received formal approval from the FDA to administer the fourth dose of this vaccine.
“Recent clinical studies in Israel and other European countries have provided scientific evidence that the fourth dose of Pfizer COVID-19 mRNA vaccine affords enhanced protection against the Omicron variant” said Sohail Rao, MD, MA, DPhil, President and CEO, DHR Health Institute for Research & Development. “Given that Omicron is the dominant variant which is responsible for the current spike in COVID-19 cases in the US, we are pleased to offer this option to continue to keep our community safe.”
To qualify for the fourth dose, you must be a healthcare worker, or above the age of 65 years, or have an immunocompromised status. The fourth dose can be administered 90 days after the third dose of the Pfizer COVID-19 mRNA vaccine. If you have been recently diagnosed with COVID-19, you can also receive the fourth dose 21 days after complete resolution of your symptoms. As part of this protocol, the level of antibodies against the virus that causes COVID-19 will also be measured in the blood before administering the fourth dose and at frequent intervals thereafter and the results of these tests will be provided to the patient in a timely manner.
If you or your patient is interested to receive the fourth dose, please call 956-362-2392 or 956-362-2387; or send an email [email protected]; or fax with relevant patient information to 956-362-2383
-more-
About DHR Health Institute for Research & Development
DHR Health Institute for Research & Development, is a nonprofit organized under the Federal Internal Revenue Service Code 501(c)(3). As the largest and the most comprehensive entity conducting translational and clinical research in South Texas, DHR Health Institute for Research and Development leads the way in bringing innovative, state-of-the-art advanced treatment options for our patients in the community. With sites in Edinburg, TX, Brownsville, TX, and soon in Rio Grande City, TX, DHR Health Institute for Research and Development provides oversight of translational and clinical research at DHR Health, DHR Health Brownsville, Starr County Memorial Hospital, and all clinics under the Renaissance Medical Foundation. To learn more, visit the website at www.dhrresearch.org.
About DHR Health
DHR Health was founded in 1997 to help over 1.4 million residents resolve limited health care access challenges in a community that lacked public and county hospitals. Today, it is a modern, 600+ bed full-service health system serving over 280,000 patients annually, with 5500+ employees, over 650 physicians and more than 1,400 nurses dedicated to offering a full continuum of care in over 70 different specialties and subspecialties. As the only Level 1 Trauma Center in South Texas, DHR Health proudly boasts the best specialty care in the region, a 24/7 functioning level-one trauma center, a robust clinical research division, and developing graduate medical education programs. DHR Health has revolutionized the health care landscape of the Rio Grande Valley and continues to raise the standard of care and transform the health care delivery model for the benefit of all local residents. To learn more, visit this website at www.dhrhealth.com
